Skip to main content
Erschienen in: Cancer Causes & Control 7/2010

01.07.2010 | Original paper

Head injury, diagnostic X-rays, and risk of medulloblastoma and primitive neuroectodermal tumor: a Children’s Oncology Group study

verfasst von: Saira Khan, Alison A. Evans, Lucy Rorke-Adams, Manuela A. Orjuela, Tania Shiminski-Maher, Greta R. Bunin

Erschienen in: Cancer Causes & Control | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

A comprehensive case–control study was conducted to determine potential risk factors for medulloblastoma/primitive neuroectodermal tumor (PNET), a common brain tumor in children. This analysis evaluated possible associations between previous head injury and ionizing radiation exposure through diagnostic X-rays and medulloblastoma/PNET.

Methods

Mothers of 318 cases <6 years of age at diagnosis between 1991 and 1997 and registered with the Children’s Oncology Group were interviewed. Mothers of 318 matching controls were selected through random digit dialing and interviewed.

Results

An association was not detected between previous head injury (OR: 0.78, 95% CI: 0.40–1.5) or head X-ray for any reason including head injury with medulloblastoma/PNET. A statistically non-significant excess of cases reported having an X-ray for reason other than head injury (OR 2.3, 95% CI 0.91–5.7). When cases that received an X-ray for a common symptom of medulloblastoma/PNET were considered unexposed this association weakened (OR: 1.3, 95% CI: 0.49–3.7). No dose–response relationship was observed.

Conclusions

Head injury and exposure to diagnostic head X-rays were not associated with medulloblastoma/PNET in this study. Future studies should investigate all imaging procedures with ionizing radiation exposure including computed tomography scans and utilize radiation dose estimations.
Literatur
1.
Zurück zum Zitat US Cancer Statistics Working Group (2005) United States Cancer Statistics: 2002 incidence and mortality. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Cancer Institute, Atlanta, GA US Cancer Statistics Working Group (2005) United States Cancer Statistics: 2002 incidence and mortality. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Cancer Institute, Atlanta, GA
2.
Zurück zum Zitat Pomeroy SL, Tamayo P, Gaasenbeek M et al (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436–462CrossRefPubMed Pomeroy SL, Tamayo P, Gaasenbeek M et al (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436–462CrossRefPubMed
3.
Zurück zum Zitat Surveillance, Epidemiology, and End Results (SEER) Program (2004) Public-use data (1973–2001). Cancer Statistics Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD Surveillance, Epidemiology, and End Results (SEER) Program (2004) Public-use data (1973–2001). Cancer Statistics Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD
4.
Zurück zum Zitat Gurney JG, Smith MA, Bunin GR (1999) CNS and miscellaneous intracranial and intraspinal neoplasms. In: Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds) Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. National Cancer Institute, SEER Program, Bethesda, MD, pp 51–63 Gurney JG, Smith MA, Bunin GR (1999) CNS and miscellaneous intracranial and intraspinal neoplasms. In: Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds) Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. National Cancer Institute, SEER Program, Bethesda, MD, pp 51–63
5.
Zurück zum Zitat Ron E, Modan B, Boice JD et al (1988) Tumors of the brain and central nervous system after radiotherapy in childhood. N Engl J Med 319:1033–1039PubMed Ron E, Modan B, Boice JD et al (1988) Tumors of the brain and central nervous system after radiotherapy in childhood. N Engl J Med 319:1033–1039PubMed
6.
Zurück zum Zitat National Institute of Environmental Health Sciences (2004) Report on Carcinogens, 11th edn. US Department of Health and Human Services, Public Health Service, National Toxicology Program National Institute of Environmental Health Sciences (2004) Report on Carcinogens, 11th edn. US Department of Health and Human Services, Public Health Service, National Toxicology Program
7.
Zurück zum Zitat Stewart A, Webb J, Hewitt D (1958) A survey of childhood malignancies. Br Med J 1:1495–1508CrossRefPubMed Stewart A, Webb J, Hewitt D (1958) A survey of childhood malignancies. Br Med J 1:1495–1508CrossRefPubMed
8.
Zurück zum Zitat Harvey EB, Boice JD, Honeyman M, Flannery JT (1985) Prenatal X-ray exposure and childhood cancer in twins. N Engl J Med 312:541–545PubMedCrossRef Harvey EB, Boice JD, Honeyman M, Flannery JT (1985) Prenatal X-ray exposure and childhood cancer in twins. N Engl J Med 312:541–545PubMedCrossRef
9.
Zurück zum Zitat Bunin GR, Robison LL, Biegel JA, Pollack IF, Rorke-Adams LB (2006) Parental heat exposure and risk of childhood brain tumor: a Children’s Oncology Group study. Am J Epidemiol 164:222–231CrossRefPubMed Bunin GR, Robison LL, Biegel JA, Pollack IF, Rorke-Adams LB (2006) Parental heat exposure and risk of childhood brain tumor: a Children’s Oncology Group study. Am J Epidemiol 164:222–231CrossRefPubMed
10.
Zurück zum Zitat Schuz J, Kaletsch U, Kaatsch P, Meinert R, Michaelis J (2000) Risk factors for pediatric tumors of the central nervous system: results from a German population-bases case-control study. Med Pediatr Oncol 36:274–282CrossRef Schuz J, Kaletsch U, Kaatsch P, Meinert R, Michaelis J (2000) Risk factors for pediatric tumors of the central nervous system: results from a German population-bases case-control study. Med Pediatr Oncol 36:274–282CrossRef
11.
Zurück zum Zitat Gurney JG, Preston-Martin S, McDaniel AM, Mueller BA, Holly EA (1996) Head injury as a risk factor for brain tumors in children: results from a multicenter case-control study. Epidemiology 7:485–489CrossRefPubMed Gurney JG, Preston-Martin S, McDaniel AM, Mueller BA, Holly EA (1996) Head injury as a risk factor for brain tumors in children: results from a multicenter case-control study. Epidemiology 7:485–489CrossRefPubMed
12.
Zurück zum Zitat Preston-Martin S, Mack W, Henderson BE (1989) Risk factors for gliomas and meningiomas in males in Los Angeles County. Cancer Res 49:6137–6143PubMed Preston-Martin S, Mack W, Henderson BE (1989) Risk factors for gliomas and meningiomas in males in Los Angeles County. Cancer Res 49:6137–6143PubMed
13.
Zurück zum Zitat Preston-Martin S, Yu MC, Benton B, Henderson BE (1982) N-nitroso compounds and childhood brain tumors: a case-control study. Cancer Res 42:5240–5245PubMed Preston-Martin S, Yu MC, Benton B, Henderson BE (1982) N-nitroso compounds and childhood brain tumors: a case-control study. Cancer Res 42:5240–5245PubMed
14.
Zurück zum Zitat Inskip PD, Mellemkjaer L, Gridley G, Olsen JH (2004) Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control 9:109–116CrossRef Inskip PD, Mellemkjaer L, Gridley G, Olsen JH (2004) Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control 9:109–116CrossRef
15.
Zurück zum Zitat Preston-Martin S, Pogoda JM, Schlehofer B et al (1998) An international case-control study of adult glioma and meningioma: the role of head trauma. Int J Epidemiol 27:579–586CrossRefPubMed Preston-Martin S, Pogoda JM, Schlehofer B et al (1998) An international case-control study of adult glioma and meningioma: the role of head trauma. Int J Epidemiol 27:579–586CrossRefPubMed
16.
Zurück zum Zitat Nyrgen C, Adami J, Weimin Y et al (2001) Primary brain tumors following traumatic brain injury: a population-based cohort study in Sweden. Cancer Causes Control 12:733–737CrossRef Nyrgen C, Adami J, Weimin Y et al (2001) Primary brain tumors following traumatic brain injury: a population-based cohort study in Sweden. Cancer Causes Control 12:733–737CrossRef
17.
Zurück zum Zitat Bunin GR, Buckley JD, Boesel CP, Rorke LB, Meadows AT (1994) Risk factors for astrocytic glima and primitive neuroectodermal tumor of the brain in young children: a report from the Children’s Cancer Group. Caner Epidemiol Biomarkers Prev 3:197–204 Bunin GR, Buckley JD, Boesel CP, Rorke LB, Meadows AT (1994) Risk factors for astrocytic glima and primitive neuroectodermal tumor of the brain in young children: a report from the Children’s Cancer Group. Caner Epidemiol Biomarkers Prev 3:197–204
18.
Zurück zum Zitat Howe GR, Burch JD, Chiarelli AM, Risch A, Choi BCK (1989) An exploratory case-control study of brain tumors in children. Cancer Res 49:4349–4352PubMed Howe GR, Burch JD, Chiarelli AM, Risch A, Choi BCK (1989) An exploratory case-control study of brain tumors in children. Cancer Res 49:4349–4352PubMed
19.
Zurück zum Zitat Hammer GP, Seidenbusch MC, Schneider K et al (2009) A cohort study of childhood incidence after postnatal diagnostic X-ray exposure. Radiat Res 171:504–512CrossRefPubMed Hammer GP, Seidenbusch MC, Schneider K et al (2009) A cohort study of childhood incidence after postnatal diagnostic X-ray exposure. Radiat Res 171:504–512CrossRefPubMed
20.
Zurück zum Zitat Halperin EC, Watson DM, George SL (2001) Duration of symptoms prior to diagnosis is related to inversely presenting disease stage in children with medulloblastoma. Cancer 91:1444–1450CrossRefPubMed Halperin EC, Watson DM, George SL (2001) Duration of symptoms prior to diagnosis is related to inversely presenting disease stage in children with medulloblastoma. Cancer 91:1444–1450CrossRefPubMed
22.
Zurück zum Zitat Linton OW, Mettler FA (2003) National conference on dose reduction in CT, with an emphasis on pediatric patients. Am J Roentgenol 181:321–329 Linton OW, Mettler FA (2003) National conference on dose reduction in CT, with an emphasis on pediatric patients. Am J Roentgenol 181:321–329
23.
Zurück zum Zitat Linet MS, Kim KP, Rajaraman P (2009) Children’s exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations. Pediatric Radiol 39:S4–S26CrossRef Linet MS, Kim KP, Rajaraman P (2009) Children’s exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations. Pediatric Radiol 39:S4–S26CrossRef
24.
Zurück zum Zitat West SL, Strom BL, Poole C (2005) Validity of pharmacoepidemiologic drug and diagnosis data. In: Strom BL (ed) Pharmacoepidemiology, 4th edn. Wiley, Chichester, pp 709–765 West SL, Strom BL, Poole C (2005) Validity of pharmacoepidemiologic drug and diagnosis data. In: Strom BL (ed) Pharmacoepidemiology, 4th edn. Wiley, Chichester, pp 709–765
25.
Zurück zum Zitat Gama H, Correia S, Lunet N (2009) Questionnaire design and the recall of pharmacological treatments: a systematic review. Pharmacoepidemiol Drug Saf 18:175–187CrossRefPubMed Gama H, Correia S, Lunet N (2009) Questionnaire design and the recall of pharmacological treatments: a systematic review. Pharmacoepidemiol Drug Saf 18:175–187CrossRefPubMed
Metadaten
Titel
Head injury, diagnostic X-rays, and risk of medulloblastoma and primitive neuroectodermal tumor: a Children’s Oncology Group study
verfasst von
Saira Khan
Alison A. Evans
Lucy Rorke-Adams
Manuela A. Orjuela
Tania Shiminski-Maher
Greta R. Bunin
Publikationsdatum
01.07.2010
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 7/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9529-2

Weitere Artikel der Ausgabe 7/2010

Cancer Causes & Control 7/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.